Product Features

PRODUCT FEATURES BROUGHT TO YOU BY PFIZER

Familiar Features

Supplied the same way as reference bevacizumab1

  • Available in 100mg/4 mL and 400 mg/16 mL

Storage Features 

Flexible storage options1

  • ZIRABEV® can be stored in refrigeration (2°C-8°C) until expiry shown on the vial.
  • ZIRABEV® has demonstrated chemical and physical in-use stability for a period of up to 35 days at 2°C-8°C after dilution and for up to 48 hours at temperatures not exceeding 30°C in sodium chloride 9 mg/mL (0.9%) solution for injection.
  • Keep the vial in the outer carton in order to protect from light.

Additional Features

Innovative vial solutions2,3

  • Tamper protective seal ensures the safety and security of every individual vial.
  • Latex free stopper ensures anyone with a latex allergy can safely handle the vial.

Scanning for tracking and traceability2,3 

  • Cartons provide scannable information for inventory tracking.
  • Vials are scannable for electronic medical records.
  • Scanning the barcode on the vial as well as the box allows for identification and authentication of individual packs.

Potential to conserve refrigerator space2,3 

  • Box dimension are 4.5cm x 4.5cm x 7cm.

References:

1. ZIRABEV® (bevacizumab) Summary of Product Characteristics.
2. Data on file. Pfizer Healthcare Ireland Regulatory Department. 2020.
3. Office Journal of the European Union. Directive 2011/62/EU of the European Parliament and of the Council. https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:174:007.... Accessed March 2021.

 

PP-BIO-IRL-0130. Preparation Date: April 2021.